Nezha Benabdallah

@nsbenab.bsky.social

Group leader at the University of Edinburgh. Chromatin, Gene Regulation & Sarcoma https://www.benabdallah-lab.com/

"Somewhere in a university shared drive, there is probably an Athena Swan action plan that took months to produce, drew on years of data, involved hours of unpaid or under-recognised labour, and identified inequalities that everyone agreed mattered." This really hit home.

Wonkhe@wonkhe.bsky.social · 3w ago

NEW on Wonkhe: How do we move from collecting evidence and designing frameworks to meaningful transformation? Lauren Flannery and Helen Leggett look for accountability for equalities work buff.ly/fjZhGND

The @US_FDA granted traditional approval to the targeted therapy selpercatinib for patients 2 and older with advanced solid tumors that have a RET gene fusion whose disease progressed on or following systemic treatment or who have no alternative options: buff.ly/Od4Phzl

FDA grants traditional approval to selpercatinib for locally advanced

FDA grants traditional approval to selpercatinib for locally advanced or metastatic RET fusion-positive solid tumors

fda.gov

Very honoured that the lab has been selected as the first UK Center for Excellence by the CdLS foundation www.cdlsusa.org/centers-for-.... We aim to advance knowledge about this genetic condition and to explore similarities to other rare genetic disorders that affect gene regulation.

Centers for Excellence | CdLS Foundation

Our expanded Centers of Excellence network is here — 8 designated centers, 10+ lead investigators, and the people turning lived experience into discovery. See who's part of Mission Possible.

cdlsusa.org

Each year, we highlight companies that received sizeable early-stage funding in the previous year. Trogenix's platform for generating ‘synthetic super-enhancers’ could drive highly cell-specific gene therapy-based treatment of solid tumors such as glioblastoma www.nature.com/articles/s41...

Editor’s pick: Trogenix - Nature Biotechnology

Each year, Nature Biotechnology highlights companies that received sizeable early-stage funding in the previous year. Trogenix has developed a platform for generating ‘synthetic super-enhancers’ that ...

nature.com

“It’s just a microscopic water droplet surrounded by a fatty membrane and stuffed with chemicals and snippets of DNA encoding a mere 36 genes. But it’s also arguably the closest researchers have come to building a living cell from scratch.”🧪 My story in @science.org on a fascinating preprint:

Lab-created ‘SpudCell’ marks ‘stunning’ step toward building life from scratch

A synthetic cell can now grow and divide—but it’s still far from alive

science.org

I have been thinking since yesterday about why I find the 1% thing so, so disturbing. It's a visceral reaction of 'just no', which goes beyond the general yuck towards the enshittification of/via AI. I have finally put my finger on it: it is the feeling you get when

I know it seems like a heretical idea, but one way to figure out if a preprint is really interesting (to you) is... to read the preprint. Then, in the spirit of sharing, send a note to authors: a simple kudos or a more detailed question. I do this a dozen times a year. It's awesome. Try it.

When reality surpasses fiction! Top: fictional forecast for August 2050, broadcast by French TV in 2014 to warn about the consequences of global warming. Bottom: Real French forecast for yesterday, June 22, 2026.

Bild

Let's step inside a neuron together, and ask, "how did all this get here?" 🤔 In this review, I trace the history and transformations of a neuron's molecules, pay homage to major discoveries in brain development ... and make a call to action for neuroscience. www.annualreviews.org/content/jour...

The Translation of Genetic Information in Neurodevelopment

Neurodevelopment is the transformation of genetic information into diverse neuronal phenotypes. Developmental signals initiate patterns of gene transcription and translation that drive progenitors tow...

annualreviews.org

⚡New preprint from the lab⚡: A key early checkpoint in gene expression is promoter proximal pausing of RNA polymerase II. For over 20 years, we as field have not been able to recreate pausing under realistic cellular conditions. @robertovn.bsky.social shows that ELOF1 is the missing piece.

Roberto Vázquez Núñez@robertovn.bsky.social · 2mo ago

🚨 New preprint: GATO-seq did it again! ELOF1 is the missing promoter-proximal factor that confers RNA Pol II resistance to TFIIF. Including ELOF1, DSIF, and NELF in GATO-seq reactions recapitulates promoter-proximal pausing in vitro at physiological conditions for the 1st time. tinyurl.com/ELOF1

Help please! We need to do some large(ish) cell culture inhibiting E-cadherin with a monoclonal antibody. Does anyone have the DECMA-1 hybridoma cell line so we could purify our own antibody? or a similar monoclonal that would do the job. Any help greatly appreciated, just DM me. Please repost!